SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-16-006171
Filing Date
2016-11-14
Accepted
2016-11-14 17:37:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422010_11142016.htm SC 13G 195428
2 JOINT FILING AGREEMENT ex991to13g07422010_11142016.htm EX-99.1 32723
  Complete submission text file 0000921895-16-006171.txt   229808
Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Subject) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88256 | Film No.: 161996339
SIC: 2834 Pharmaceutical Preparations